BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35292188)

  • 21. Predictors of sentinel lymph node status of cutaneous melanoma in Serbian patients.
    Jokic S; Markovic I; Bukumiric Z; Jokic V; Rakovic M; Tripkovic J; Stojiljkovic D; Spurnic I; Jevric M; Matic M; Dobrosavljevic D
    J BUON; 2018; 23(2):468-474. PubMed ID: 29745094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small cell melanoma and ulceration as predictors of positive sentinel lymph node in malignant melanoma patients.
    Cuéllar FA; Vilalta A; Rull R; Vidal-Sicart S; Palou J; Ventura PJ; Pous E; Quinto L; Malvehy J; Martí R; Puig S; Vilella R; Soler J; Benítez D; Yachi E; Lecha M; Pons F; Conill C; Visa J; Castel T;
    Melanoma Res; 2004 Aug; 14(4):277-82. PubMed ID: 15305158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
    Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
    Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of sentinel lymph node status in cutaneous melanoma: a classification and regression tree analysis.
    Tejera-Vaquerizo A; Martín-Cuevas P; Gallego E; Herrera-Acosta E; Traves V; Herrera-Ceballos E; Nagore E
    Actas Dermosifiliogr; 2015 Apr; 106(3):208-18. PubMed ID: 25616352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations.
    Oh Y; Choi S; Cho MY; Nam KA; Shin SJ; Chang JS; Oh BH; Roh MR; Chung KY
    J Am Acad Dermatol; 2020 Oct; 83(4):1071-1079. PubMed ID: 31562946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of clinical and histopathological characteristics on the disease-free survival of stage I-II acral melanoma patients.
    Borges de Barros Primo R; Brito Nobre A; Santos BN; Nunes LF; Fernandes R; Abrão Possik P; Santos Bernardes S
    Int J Dermatol; 2023 Oct; 62(10):1281-1288. PubMed ID: 37596798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomas.
    Huismans AM; Haydu LE; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Thompson JF
    Ann Surg Oncol; 2014 Nov; 21(12):3985-91. PubMed ID: 24912613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
    Meier F; Will S; Ellwanger U; Schlagenhauff B; Schittek B; Rassner G; Garbe C
    Br J Dermatol; 2002 Jul; 147(1):62-70. PubMed ID: 12100186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
    Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
    Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
    Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.
    Lachiewicz AM; Berwick M; Wiggins CL; Thomas NE
    Arch Dermatol; 2008 Apr; 144(4):515-21. PubMed ID: 18427046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
    Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
    Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results.
    Vuylsteke RJ; van Leeuwen PA; Statius Muller MG; Gietema HA; Kragt DR; Meijer S
    J Clin Oncol; 2003 Mar; 21(6):1057-65. PubMed ID: 12637471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic invasion in acral and non-acral melanoma: a comparative, clinicoprognostic study of primary cutaneous melanoma according to tumour site.
    Jung JM; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
    Pathology; 2020 Oct; 52(6):670-675. PubMed ID: 32819739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up.
    Leong SP; Kashani-Sabet M; Desmond RA; Kim RP; Nguyen DH; Iwanaga K; Treseler PA; Allen RE; Morita ET; Zhang Y; Sagebiel RW; Soong SJ
    World J Surg; 2005 Jun; 29(6):683-91. PubMed ID: 15895193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
    Vízkeleti L; Ecsedi S; Rákosy Z; Orosz A; Lázár V; Emri G; Koroknai V; Kiss T; Ádány R; Balázs M
    Tumour Biol; 2012 Dec; 33(6):2189-99. PubMed ID: 23001925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
    Wei X; Wu D; Li H; Zhang R; Chen Y; Yao H; Chi Z; Sheng X; Cui C; Bai X; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Mao L; Lian B; Kong Y; Dai J; Tang B; Yan X; Wang X; Li S; Zhou L; Balch CM; Si L; Guo J
    Ann Surg Oncol; 2020 Sep; 27(9):3478-3485. PubMed ID: 32253677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphatic vessel density and VEGF-C expression as independent predictors of melanoma metastases.
    Špirić Z; Eri Ž; Erić M
    J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1653-1659. PubMed ID: 28756123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.